semperit group investor presentation · 2016. 9. 26. · semperit at a glance 2 investor...

1

SEMPERIT GROUPINVESTOR PRESENTATIONSeptember 2016

Semperit at a glance

Investor Presentation September 2016 I Investor Relations2

Solid balance-sheet structure

39%equity ratio

EUR 915million revenue

EUR 67million EBIT

Leading market position with strong brands in the Industrial and Medical Sectors for more than

190 years

Balanced portfolio

Semperflex Sempertrans Semperform Sempermed

7,053 employees

Worldwide presenceDistribution in more than 100 countries

22 production sites worldwide

Note: values stated are for FY 2015

Investment Rationale (p. 4)

Outlook (p. 21)

Appendix (p. 24)

Agenda

3

Operational Development and Financial Performance (p. 11)

Investor Presentation September 2016 I Investor Relations

Investment Rationale

5 reasons to invest in Semperit

1. Strong position in megatrend-driven markets

2. Profitable growth based on a balanced portfolio

3. Long standing application and process engineering tradition,proven M&A track record

4. High earnings capacity and strong balance sheet

5. Market leading brands, customer focused approach andglobally diversified sales network

4 Investor Presentation September 2016 I Investor Relations

1. Strong position in megatrend-driven markets

Worldwide energy demand

Population growth

Worldwide urbanisation

Global megatrends

+33% to 9.6 billion by 2050

66% urban populationby 2050 (2014: 54%)

+30% by 2035

Medical Sector: Growth market Healthcare Rising prosperity and

improving hygienic standards in emerging markets

Increasing life expectancy and shift in the age pyramid in mature markets

Ø global growth of glove market5-6% p.a.

Use of examination gloves per capita per year

60 - 70

25 - 3010 - 20

Asia South America Europe USA

Source: Semperit

150 - 160

SempermedExamination glovesGlobally leading position

Surgical glovesLeading position in Europe

5

Market impact & growth drivers Products & market position

Industrial Sector: industrialisation & investments in infrastructure On-going industrialisa-

tion and infrastructure investments

Expansion of mining industry

Growing construction business

Rising demand for Semperflex, Sempertrans and Semperform products

Global construction market until 2030 (in USD trillion)

Source: Global Construction 2030

8.4

15.5

2015 2030

+85%+85%

Semperflex

Sempertrans

Semperform

Hydraulic hoses# 3 globally, leader in hose onlyIndustrial hoses# 2-3 in Europe

Conveyor beltsTop Tier / one of the worldwide leading suppliers

Handrails: leading positionWindow profiles: European playerCable car rings and ski foils: leading position


2. Profitable growth based on a balanced portfolio

Ambitious growth strategy …

True global player through expansion in growth markets

Capacity expansions and selected acquisitions

Customer proximity, market orientation and innovation strength

High performance organisation

Growth targets Double digit volume growth 2015-2020 (CAGR)

Growth targets Double digit volume growth 2015-2020 (CAGR)

… based on stability through diversification

Stable, largely non-cyclical growth Expansion of leading global position Strengthen market position in medical

and industrial/consumer goods areas

MedicalSector

Managing industrial cycles and on-going high profitability

Leading position in selected niches Grow and maintain market positions

IndustrialSector

Revenue: Accelerated growth since 2010in EUR m

463 477 515 574 608

655 588 689

820 829 906 858 915

2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014* 2015

CAGR+4.0%

Revenue growth and high earningsin %

Source: World Bank, Semperit

Group EBITDAmargin

Industrial Sector: Revenue Growth in%

Medical Sector: Revenue Growth in%

GDP Growth World in %

CAGR+5.8%

16.3% 13.4% 13.1% 14.6% 11.9%

* restated

6

4.0 2.8 3.1 2.4 3.3

16.6 17.4

3.2

13.4

-12.4

17.8 20.2

-0.8

5.91.3

9.1

2010 2011 2012 20132014*

10.5%

2015

3.13.4


3. Long standing application and process engineering tradition,proven M&A track record

High performance organisation for accelerated growth

Long-standing engineering know-how dates back to 1824 Strong track record in high-quality production and innovative products Growth-orientated organisation to manage organic growth and acquisitions

Latexx Partners acquisition in 2012

Takeover of Malaysian gloves producer in 2012, #6 in the world

Revenue 2011: EUR 104m Employees 2011: >2,000 Expansion of the site in Kamunting with a new glove factory Investment volume: EUR 50m Production capacity: Doubling to about 12 billion units of

gloves per year (from 6 billion units)

Leeser acquisition in 2015

Takeover of leading German manufacturer of high-quality rubber seals in 2015

Revenue 2014: EUR 37m Employees 2014: >200 Acquisition strengthens market position and had an

immediate positive effect on earnings situation of Semperform Integration is proceeding successfully, first synergies

already achieved


4. High earnings capacity and strong balance sheet

Sophisticated Financial Engineering

Focused financing policy

Active cost and raw materials management

Cost awareness and rigid cost controlling on all levels

Optimised capital structure

Adaptation of pay-out ratio to about 50% of earnings after tax (provided the performance and development of the company permit it)

Strong cash generation and attractive dividend policy

Strong balance sheet and high cash position

Equity Ratioin %

Cash and cash equivalentsin EUR m

29.4

106.7

137.2

71.559.8

2011 2012 2013 2014 2015

Operating Cash flowin EUR m

Dividend per sharein EUR

1) 0.90 basic dividend + 0.30 anniversary bonus2) 1.10 basic dividend + 4.90 one-time special

0.8 0.8 1.2

6.0

1.2

2011 2012 2013 2014 2015

61.549.3 48.3

53.7

38.7

2011 2012 2013 2014 2015

97.9

133.3

182.6

115.6 126.4

2011 2012 2013 2014 2015

1)

2)


5. Market leading brands, customer focused approach and globally diversified sales network

Products• Leading Sempermed brands with

broad product portfolio• OEM production for customers worldwide

Distribution• Multi-channel distribution capabilities with

sales offices in Europe, North & South America and Asia

Products• Diversified product range in attractive niches • From basic to premium products to

tailor-made / project business

Distribution• Focus on high reputation customers • Strong partners in wholesale

Medical Sector: Revenue by region

Europe55%

Asia, Africa, other10%

North & South America35%

FY 2015 in %

Industrial Sector: Revenue by region

Europe74%

Asia, Africa, other15%

North & South America11%

FY 2015 in %



Outlook (p. 21)

Appendix (p. 24)

Agenda

10



Stable operational development despite strong headwind

Stable operational development through successful sales activities

Enhanced global presence and satisfying capacity utilisation

Strong performance of Industrial Sector despite declining markets

Medical Sector with weaker performance due to negative impact of Thailand JV, cost increases and price pressure

Slight drop in revenue and stable operational earnings Revenue decreases by -2.7% to EUR 438.7 million EBITDA +4.8% and unchanged EBIT1)

Net profit negatively impacted by higher financial and tax expenses

Strong performance of Industrial Sector largely compensated weaker development of Medical Sector

Revenue by segment H1 2016 (vs. H1 2015)Sempermed39% (43%)

Semperform18% (16%)

Sempertrans19% (17%)

Semperflex24% (24%)

Europe71% (65%)

Asia, Africa, others11% (13%)

North and South America 18% (22%)

Revenue by region H1 2016 (vs. H1 2015)

1) Values for H1 2015 restated


• Satisfactorily booked capacities, despite challenging market environment

• Commodity prices started to stabilise, but weak market demand and price pressure continue

Successfully defending position in incumbent markets and winning market shares in new market segments

Good utilisation of new capacities through strategic alliances with key customers

New industrial hose factory in Odry: first trial production started

Hydraulic hoses: Strong sales performance in Europe and successful launch of new spiral hose

Semperflex: Good performance Sempertrans: Winning market shares

H1 2016 vs. H1 20151)


Sem

perf

lex

Sem

pert

rans

-10%Market

EBIT

EBITDA

Revenue

-10%Market

EBIT

EBITDA

Revenue

-1.5%

+1.2%

+0.1%

+4.7%

+9.8%

+8.1%


Challenging conditions: Global glove market is not absorbing cost increases

Negative impact of Thai JV, but all ICC arbitrations in favor of Semperit up to now

Cost reduction programme started Quality of plant ramp up above expectations,

but slight delay of volume output; start-up costs put pressure on earnings

• Good profitability development due to sales performance and cost control measures

Integration of Leeser largely completed and new extrusion line put into operation

Global market share wins in handrail business lead to strong sales volume

Semperform: Good profitabilitySempermed: Challenging conditions

H1 2016 vs. H1 20151)Se

mpe

rfor

mSe

mpe

rmed

-2%Market

EBIT

EBITDA

Revenue

+5%

-31.7%

-11.4%

Market

EBIT

EBITDA

Revenue

1) Values for H1 2015 restated2) EBITDA and EBIT in H1 2015 was positively influenced by one-time bad will effect from acquisition of Leeser (about EUR 3m).

+10.2%

-1.2%

-12.5%

13

-78.1%


2)

H1 2016: Slight drop in revenue, stable EBIT

1) Values for H1 2015 restated2) Attributable to the shareholders of Semperit AG Holding

in EUR mH1 2016 H1 2015

1)

(restated) %

Revenue 438.7 450.8 -2.7%

EBITDA 52.8 50.3 +4.8%

EBIT 36.2 36.2 ±0.0%

Earnings after tax 17.9 25.3 -29.3%

Profitability

EBITDA margin 12.0% 11.2% +0.8 PP

EBIT margin 8.3% 8.0% +0.3 PP

Earnings per share in EUR2) 0.87 1.23 -29.3%

Key Financials Semperit Group1)


Development of revenue and EBIT per quarter

15,2 18,6

21,0 17,6

17,7

12,8

Q1

Q2

Q3

Q4

2016

36.2

20151)

66.7

7.0%

9.0%

7.3%

= EBIT margin

15

20151)

Q2

Q3

Q4

2016

438.7

219.5

219.2

914.7

217.5

233.4

241.3

222.6

Q1

5.8%

Revenue per quarterin EUR m

EBIT per quarterin EUR m

8.5%

8.0%

1) Values for 2015 restated

8.0%


Sempertrans and Semperform with further revenue growth

Semperform

-21.8

Semperflex

450.8

H1 2016

3.7+9.7 millionIndustrial Sector

-1.6

Sempertrans

7.6

H1 2015 Sempermed

438.7

-2.7%

Revenue by segment H1 2015 vs. H1 2016in EUR m

-11.4%

Industrial Sector Medical Sector

-1.5% +4.7% +10.2%

+3.7%

= % change+3.7%


Excellent EBIT margins in Industrial Sector

36,25,00,70,036,2

Sempermed

-4.3

Semperform

-1.5

±0.0%

-0.7 millionIndustrial Sector

H1 2016Corporate Center

SempertransSemperflexH1 20151)

EBIT by segment H1 20151) vs. H1 2016in EUR m

8.3%8.0%

15.9% = EBIT margin

0.7%21.5% 11.7% 12.6%

15.9%




Negative effects on financial result in H1 2016

18

Financial result H1 2015in EUR m

-4.2

-2.6

-11.7

12.9

-2.8

Financialresult

-10.0Interest expenses

-3.5

Financialexpenses incl. FX losses and other expenses

-13.1

Financialincome incl.

FX gains and interest income

9.7

Profit/loss attribu-table to redeem-

able non-con-trolling interests

-3.1

Financial result H1 2016in EUR m

H1 2015: Financial result primarily influenced by FX gains

H1 2016: Negative impact of FX losses (mainly in Q1 2016) and higher borrowing on financial result

Development of financial result


CAPEX and Working Capital Overview

= Trade Working Capital in % of LTM revenues

12,6 11,3

3,1 4,7

7,9

4,1

3,43,4

5,3

-22.5%

Other

Sempermed

SemperformSempertransSemperflex

H1 2016

25.0

1.5

H1 2015

32.3

CAPEX per Segmentin EUR m

Components of Working Capitalin EUR m

17.6%

125,5 134,2

135,7 130,2

-95,8

+5.0%

Trade payables

Trade receivables

Inventories

30 June 2016

168.7

31 Dec 2015

160.6

-100.7

17.6% 18.7%



Outlook (p. 21)

Appendix (p. 24)

Agenda

20



Outlook 2016: Challenging market conditions weigh on operational development

Heterogeneous picture in emerging and developing countries

No signs of stimulation of industry and investments in China, Russia and Eastern Europe

Moderate economic recovery expected in 2017 in the industrialised countries

Flat development of the global economy in 2016

Operational results expected to be below prior year: EBITDA about -10%, EBIT about -20%

Risk factors: uncertain outlook for commodity prices and currency risks

Industrial Sector Semperflex: Relatively stable, better than market,

strong market position and strategic partnerships mitigate cyclicality Sempertrans: Cyclical decreasing demand,

price pressure intensified, development in accordance with market

Semperform: Relatively stable, globalisation of profile business, positive contribution from Leeser

Medical Sector Focus on commissioning of the new

production capacities in Malaysia Efficiency, optimisation and cost cutting

measures under way Negative impact from joint venture

in Thailand likely to continue

Markets put pressure on operational development

Growth targets

Average double-digit volume growth 2015-2020 (CAGR)


Contact and financial calendar

22

Financial Calendar 201617/11/2016 Report on Q1-3 2016

Financial Calendar 201723/3/2017 Publication of 2016 annual financial

statements and press conference26/4/2017 Annual General Meeting2/5/2017 Ex-dividend day4/5/2017 Dividend payment day16/5/2017 Report on Q1 201717/8/2017 Report on H1 201716/11/2017 Report on Q1-3 2017

Investor Relations Semperit GroupStefan Marin, Head of Investor [email protected]+43 1 79777 - 210www.semperitgroup.com/en/irModecenterstrasse 22 1031 Vienna, Austria

DisclaimerThe information provided in this presentation does not constitute an offer for the sale of securities nor an invitation to submitan offer to purchase shares of Semperit AG Holding, but exclusively serves information purposes. Rounding of differences inthe totalling of rounded amounts and percentages may arise from the automatic processing of data.

The forecasts, plans and forward-looking statements contained in this presentation are based on the knowledge andinformation available and the assessments made at the time that this report was prepared. As is true of all forward-lookingstatements, these statements are subject to risk and uncertainties. As a result, the actual events may deviate significantlyfrom these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of plannedtargets or for any other forward-looking statements.



Outlook (p. 21)

Appendix (p. 24)

Agenda

23



In EUR m

Revenue

EBITDA

EBITDA margin

EBIT

EBIT margin

Earnings after tax

Earnings per share in EUR3)

Investments

Employees (at reporting date)

Group and Sectors: H1 2016 vs. H1 2015

H1 2016 H1 2015restated2) %

269.0 259.3 +3.7%

52.3 51.1 +2.3%

19.4% 19.7% -0.3 PP

42.7 43.4 -1.7%

15.9% 16.7% -0.8 PP

10.3 16.3 -37.1%

3,570 3,571 ±0.0%


H1 2016 H1 2015restated2) %

169.7 191.5 -11.4%

7.9 11.6 -31.7%

4.7% 6.0% -1.3 PP

1.2 5.5 -78.1%

0.7% 2.9% -2.2 PP

11.3 12.6 -10.0%

3,337 3,630 -8.1%

H1 2016H1 2015restated2)

%

438.7 450.8 -2.7%

52.8 50.3 +4.8%

12.0% 11.2% +0.8 PP

36.2 36.2 ±0.0%

8.3% 8.0% +0.3 PP

17.9 25.3 -29.3%

0.87 1.23 -29.3%

25.0 32.3 -22.5%

7,136 7,311 -2.4%

Semperit Group1)

1) Including Corporate Center (Holding, central functions, special projects): Costs of EUR 7.6m in H1 2016 (EUR 12.6m in H1 2015)2) Values for H1 2015 restated 3) Attributable to shareholders of Semperit AG Holding


Semperit Group per quarter

in EUR m FY 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 FY 2015 Q1 2016 Q2 2016

Revenue 858.3 217.5 233.4 241.3 222.6 914.7 219.5 219.2

EBITDA 101.9 21.8 28.5 25.1 20.8 96.2 26.7 26.1

EBITDA margin 11.9% 10,0% 12,2% 10,4% 9,4% 10.5% 12.2% 11.9%

EBIT 63.8 15.2 21,0 17.7 12.8 66.7 18.6 17.6

EBIT margin 7.4% 7,0% 9,0% 7,3% 5,8% 7.3% 8.5% 8.0%

Financial result -11.5 1.0 -5.2 -0.8 -3.0 -8.0 -5.9 -4.1

Earnings after tax 37.8 12.6 12.7 14.7 6.3 46.4 10.1 7.7

Earnings per share in EUR2) 1.85 0.61 0.62 0.72 0.31 2.26 0.49 0.38

Key Financials Semperit Group1)

1) Values for 2014 and 2015 restated2) Attributable to shareholders of Semperit AG Holding


Semperflex and Sempertrans per quarter


Revenue 202.1 55.4 52.5 48.3 47.1 203.4 52.8 53.6

EBITDA 48.5 13.6 13.3 11.0 8.3 46.1 13.3 13.9

EBITDA margin 24.0% 24.6% 25.3% 22.7% 17.6% 22.7% 25.2% 26.0%

EBIT 36.8 11.6 11.3 9.0 6.3 38.2 11.1 11.8

EBIT margin 18.2% 21.0% 21.5% 18.6% 13.4% 18.8% 21.1% 22.0%

Key Financials Semperflex1)

Key Financials Sempertrans1)


Revenue 146.4 38.9 39.0 43.9 43.1 164.9 42.6 38.9

EBITDA 20.9 4.7 5.7 6.2 6.5 23.2 5.8 5.7

EBITDA margin 14.3% 12.2% 14.6% 14.1% 15.1% 14.0% 13.6% 14.5%

EBIT 16.8 4.0 4.9 5.4 5.7 19.9 4.8 4.7

EBIT margin 11.5% 10.2% 12.5% 12.2% 13.2% 12.1% 11.3% 12.1%

1) Values for 2014 and 2015 restated


Semperform and Sempermed per quarter

Key Financials Semperform1)

Key Financials Sempermed1)


Revenue 129.0 31.8 41.7 44.0 35.3 152.8 38.2 42.8

EBITDA 18.6 3.7 10.1 7.3 3.2 24.3 6.0 7.7

EBITDA margin 14.5% 11.6% 24.2% 16.7% 9.0% 15.9% 15.6% 17.9%

EBIT 12.7 2.8 8.8 5.9 1.5 19.1 4.3 5.9

EBIT margin 9.9% 8.9% 21.2% 13.4% 4.4% 12.5% 11.2% 13.8%


Revenue 380.8 91.4 100.1 105.1 97.0 393.7 85.9 83.8

EBITDA 33.5 4.8 6.8 7.8 10.0 29.4 6.1 1.8

EBITDA margin 8.8% 5.2% 6.8% 7.5% 10.3% 7.5% 7.0% 2.2%

EBIT 17.6 1.9 3.6 4.9 6.9 17.2 2.9 -1.7

EBIT margin 4.6% 2.1% 3.5% 4.6% 7.1% 4.4% 3.3% -2.0%

1) Values for 2014 and 2015 restated


Conservative financial policy provides for solid balance sheet structure and financial flexibility

Balance sheet structure 30 June 2016

Balance sheet total: EUR 973 m

Equity

Fixedassets

Inventories

Trade receivables

Cash and cash equivalents

Liabilities from redeemable non-controlling interests

Provisions incl. social capital

Other liabilities incl. deferred taxes

Current assets

Corporate Schuldschein loan

Liabilities to banks

Cash and cash equivalents of more than EUR 133m despite investment programme and optimisation of capital structure

Financial liabilities: Syndicated loan facility of EUR 250m Corporate Schuldschein loan of EUR 136m Net debt of EUR 214m

Net debt / EBITDA of 2.16x

Equity ratio of 36.7%

Financial profile as of 30 June 2016

552

130

47

134

72

210

133

136

359

149

Equity & LiabilitiesAssets

24


Key figures consolidated income statement

Key figures income statement

in EUR m Q2 2016 Q2 2015 (restated)1) % H1 2016H1 2015

(restated)1) %

Revenue 219.2 233.4 -6.1% 438.7 450.8 -2.7%

Changes inventories -2.9 0.9 – -3.8 3.0 –

Own work capitalised 0.9 2.1 -57.9% 2.2 3.1 -28.4%

Other operating income 4.0 4.9 -17.8% 5.7 7.0 -19.5%

Material costs -123.2 -139.5 -11.7% -247.0 -273.3 -9.6%

Personnel expenses -44.5 -42.8 +4.0% -87.9 -83.6 +5.2%

Other operating expenses -28.0 -34.1 -17.8% -57.9 -63.6 -8.9%

Share of profits from joint ventures and associated companies 0.6 3.6 -82.4% 2.8 6.9 -59.1%

EBITDA 26.1 28.5 -8.6% 52.8 50.3 +4.8%

Depreciation -8.4 -7.5 +12.9% -16.5 -14.1 +17.3%

EBIT 17.6 21.0 -16.2% 36.2 36.2 ±0.0%

Financial result -4.1 -5.2 20.2% -10.0 -4.2 >+100%

Earnings before tax 13.5 15.9 -14.9% 26.2 32.0 -18.1%

Income taxes -5.8 -3.1 +84.6% -8.3 -6.7 +23.9%

Earnings after tax 7.7 12.7 -39.2% 17.9 25.3 -29.3%

Earnings per share in EUR2) 0.38 0.62 -39.2% 0.87 1.23 -29.3%

29

1) Values for 2014 and 2015 restated2) Attributable to shareholders of Semperit AG Holding


Balance sheet structure: Assets

in EUR thousand 30/06/2016 31/12/2015ASSETSNon-current assetsIntangible assets 116,169 111,314Tangible assets 294,777 276,630Investments in joint ventures and associated companies

106,567 102,670

Other financial assets 10,926 12,372Other assets 8,557 5,275Deferred taxes 14,593 16,717

551,589 524,978Current assetsInventories 130,235 135,711Trade receivables 134,247 125,519Other financial assets 4,682 2,284Other assets 12,183 16,670Current tax receivables 7,232 6,192Cash and cash equivalents 132,964 126,430

421,543 412,806TOTAL ASSETS 973,132 937,784


Balance sheet structure: Equity and liabilities

EQUITY AND LIABILITIES 30/06/2016 31/12/2015EquityShare capital 21,359 21,359Capital reserves 21,503 21,503Revenue reserves 306,332 317,733Currency translation reserve 7,728 2,664Equity attributable to shareholders of Semperit AG Holding 356,922 363,260Non-controlling interests 1,997 1,924

358,919 365,183Non-current provisions and liabilitiesProvisions for pension and severance payments 44,329 40,775Other provisions 11,268 11,421Liabilities from redeemable non-controlling interests 46,706 44,192Corporate Schuldschein loan 132,644 132,615Liabilities to banks 204,607 162,898Other financial liabilities 1,263 862Other liabilities 814 746Deferred taxes 11,411 11,924

453,042 405,433Current provisions and liabilitiesProvisions for pension and severance payments 2,865 2,866Other provisions 13,412 19,033Corporate Schuldschein loan 3,187 1,481Liabilities to banks 6,063 5,560Trade payables 95,787 100,660Other financial liabilities 17,804 13,762Other liabilities 17,843 19,037Current tax liabilities 4,210 4,769

161,171 167,168EQUITY AND LIABILITIES 973,132 937,784

in EUR thousand


Key figures 2010 – 2015

Key performance figures

in EUR m 20101) 20111) 2012 2013 20143) 20153)

Revenue 689.4 820.0 828.6 906.3 858.3 914.7EBITDA 112.3 110.0 108.7 132.5 101.9 96.2EBITDA margin 16.3% 13.4% 13.1% 14.6% 11.9% 10.5%EBIT 82.3 80.4 72.5 87.8 63.8 66.7EBIT margin 11.9% 9.8% 8.8% 9.7% 7.4% 7.3%Earnings after tax 45.4 51.8 46.2 54.9 37.8 46.4Earnings per share (EPS)2), in EUR 2.21 2.52 2.25 2.65 1.85 2.26Gross cash flow 91.0 89.4 85.6 116.2 89.9 55.7Return on equity 12.9% 13.6% 11.4% 13.3% 8.6% 12.8%

Balance sheet key figures

in EUR m 20101) 20111) 2012 2013 20143) 2015Balance sheet total 593.5 616.7 824.5 852.1 826.3 937.8Equity2) 351.1 379.4 406.2 411.5 443.8 363.3Equity ratio 59.2% 61.5% 49.3% 48.3% 53.7% 38.7%Investments in tangible and intangible assets 52.5 45.1 41.2 49.7 67.4 71.8

Employees (at balance sheet date) 7,019 8,025 9,577 10,276 6,888 7,053

1) Values for 2011 restated (see Annual Report 2012, Notes 2.18), Values for 2010 not restated.2) Attributable to the shareholders of Semperit AG Holding3) Values for 2014 and 2015 restated


> 54%

> 5%

< 41%

B & C Holding Österreich GmbH, Vienna, Austria

FMR Co., Inc (FidelityManagement & Research Company)

Free Float

Semperit is listed on the Vienna Stock Exchange since 1890

Total of 20,573,434 shares with a market capitalization of aboutEUR 600m (mid August 2016)

B & C Holding Österreich GmbH is part of B & C Privatstiftung, an Austrian based private foundation / trust

Primary focus of B & C is pursuing the foundation’s mission to “foster Austrian entrepreneurship”

Semperit benefits from a supportive ownership structure with long-term commitment from B & C

Fidelity Management and Research is an American multinational financial services corporation

Shareholder structure

Shareholder Structure


semperit group investor presentation · 2016. 9. 26. · semperit at a glance 2 investor...

Documents